KLOW
GLOW plus KPV
A four-part blend that adds KPV to the GLOW recovery stack for an anti-inflammatory angle.
What it is
KLOW is the four-component sibling of GLOW: it keeps the GHK-Cu-led recovery base and adds KPV, a short peptide discussed for its anti-inflammatory and gut context. The name is simply KPV + the letters of GLOW.
As with GLOW, this page describes the composition and the reason the peptides are grouped, drawn from the component profiles. It is not dosing guidance.
Composition
What's in a 80mg vial
Sold by vendors in 80mg (50 + 10 + 10 + 10mg).
Dosing context
How KLOW is typically dosed
A common starting point is around 2 mg of GHK-Cu per dose. Because the vial is a fixed ratio, that sets how much of the other components come along. Adjust the amount to see the split.
Dose per injection
Set the GHK-Cu amount
That draws about 3.2 mg of blend, which delivers:
- GHK-Cu2 mg
- KPV0.4 mg
- TB-5000.4 mg
- BPC-1570.4 mg
Schedule. Once daily, commonly 5 days on and 2 off, in the morning. Commonly discussed in 56-day (8-week) cycles.
As with GLOW, GHK-Cu is the component the dose is sized around, and the KPV, BPC-157, and TB-500 amounts follow from the vial's fixed ratio.
Working out your reconstitution? See the GHK-Cu, KPV, TB-500 and BPC-157 calculators. These figures are educational context, not a dose recommendation.
Why these components
Why they're grouped together
- GHK-Cu. The largest component, carried over from GLOW for its skin and remodeling research context.
- KPV. The addition that distinguishes KLOW — a tripeptide discussed for anti-inflammatory and gut-related research.
- BPC-157. Repair-associated component included in small proportion.
- TB-500. Tissue-remodeling component that rounds out the recovery side.
Who it's for
KLOW comes up for people following the same skin/hair/recovery discussion as GLOW who are also interested in the anti-inflammatory literature around KPV.
Where it's sold
Live vendor pricing
All pricing →Safety context
- Four components mean four separate safety profiles to consider individually.
- As with GLOW, copper exposure from GHK-Cu is a common point of discussion.
- Verify COAs and third-party testing for each product; quality varies by vendor.
Questions people ask
What is the difference between KLOW and GLOW?
KLOW is GLOW plus KPV. Both are built on a GHK-Cu-led recovery base with BPC-157 and TB-500; KLOW adds KPV as a fourth component discussed for anti-inflammatory context.
What is in KLOW?
KPV, GHK-Cu, TB-500, and BPC-157, with GHK-Cu as the dominant share. The per-vial milligram split depends on the vial size a vendor offers.
Is KLOW safe?
KLOW combines research compounds (GHK-Cu, KPV, TB-500, BPC-157), each with its own safety profile that blending does not average away. This page is educational context, not medical advice, and does not tell you to start, stop, or combine anything. Whether any blend is appropriate is a decision for a licensed professional.
How is KLOW typically dosed?
KLOW is a fixed-ratio blend, so guidance usually describes a starting point around 2 mg of GHK-Cu per dose, with the other components delivered in proportion. Once daily, commonly 5 days on and 2 off, in the morning. This is educational context and not a dose recommendation or medical advice.
This page is for research and educational purposes only. It is not medical advice and does not diagnose, treat, prescribe, or tell you to start, stop, or combine any protocol. A licensed professional is the right person to evaluate any combination.
Other blends